SUSQUEHANNA INTERNATIONAL GROUP, LLP - CHINA PHARMA HLDGS INC ownership

CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 11 filers reported holding CHINA PHARMA HLDGS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CHINA PHARMA HLDGS INC
ValueSharesWeighting
Q4 2021$22,000
+83.3%
45,928
+63.9%
0.00%
Q4 2020$12,000
-53.8%
28,020
-71.8%
0.00%
Q4 2018$26,000
+23.8%
99,300
-4.3%
0.00%
Q3 2018$21,000
+320.0%
103,742
+314.9%
0.00%
Q2 2018$5,000
-16.7%
25,004
+36.0%
0.00%
Q1 2018$6,0000.0%18,388
-27.9%
0.00%
Q2 2017$6,000
+100.0%
25,491
+121.4%
0.00%
Q1 2017$3,000
-57.1%
11,512
-65.0%
0.00%
Q3 2016$7,000
+40.0%
32,917
+65.0%
0.00%
Q2 2016$5,000
+25.0%
19,945
+87.3%
0.00%
Q1 2015$4,00010,6470.00%
Other shareholders
CHINA PHARMA HLDGS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 58,693$42,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 195,000$141,0000.00%
HRT FINANCIAL LP 260,918$188,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 28,803$21,0000.00%
MORGAN STANLEY 500$00.00%
Citadel Advisors 46,030$33,0000.00%
Renaissance Technologies 487,479$353,0000.00%
UBS Group AG 15,416$11,0000.00%
View complete list of CHINA PHARMA HLDGS INC shareholders